Joint letter implores government to allow pharmacists to alter prescriptions
Pharmacists, GPs and patients join arms to call for law change
Read More
Author: Lucy Parsons
MSD partners with Seattle Genetics on two new oncology projects
Agreement grants MSD access to investigational ADC and a small molecule tyrosine kinase inhibitor
Read More
Shionogi launches novel antibiotic Fetcroja in the UK
The drug is indicated for use as a treatment of infections caused by aerobic Gram-negative bacteria
Read More
Novo Nordisk resumes late-stage haemophilia trials
Clinical trial programme resumes after safety concerns
Read More
Galapagos signs deal with Scipher for IBD drug development
Companies will jointly validate novel IBD targets
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
